These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective. Peny JM; Gleizes O; Covilard JP Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769 [TBL] [Abstract][Full Text] [Related]
4. [Towards a new vaccine economy?]. Poirot P; Martin JF Sante; 1994; 4(3):183-7. PubMed ID: 7921683 [TBL] [Abstract][Full Text] [Related]
5. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world. Perdue ML; Bright RA Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430 [TBL] [Abstract][Full Text] [Related]
8. Strengthening vaccination policies in Latin America: an evidence-based approach. Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196 [TBL] [Abstract][Full Text] [Related]
9. FHI to oversee AIDS vaccine trials. Netw Res Triangle Park N C; 1994 Feb; 14(3):2. PubMed ID: 12287505 [TBL] [Abstract][Full Text] [Related]
10. Should developing countries be testing grounds for vaccines rejected by the USA? AIDS Anal Afr; 1994; 4(4):2. PubMed ID: 12288157 [TBL] [Abstract][Full Text] [Related]
11. Vaccine requirements and priorities for developing countries. Thongcharoen P J Med Assoc Thai; 1986 Sep; 69(9):505-10. PubMed ID: 3794567 [TBL] [Abstract][Full Text] [Related]
12. Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices. Jadhav S; Gautam M; Gairola S Clin Microbiol Infect; 2014 May; 20 Suppl 5():37-44. PubMed ID: 24476201 [TBL] [Abstract][Full Text] [Related]
13. The association between having a medical home and vaccination coverage among children eligible for the vaccines for children program. Smith PJ; Santoli JM; Chu SY; Ochoa DQ; Rodewald LE Pediatrics; 2005 Jul; 116(1):130-9. PubMed ID: 15995043 [TBL] [Abstract][Full Text] [Related]
15. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020. Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475 [TBL] [Abstract][Full Text] [Related]
16. GAVI and the Vaccine Fund--a boon for immunization in the developing world. Balaji KA Indian J Public Health; 2004; 48(2):45-8. PubMed ID: 15709583 [TBL] [Abstract][Full Text] [Related]
17. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Menzies R; Turnour C; Chiu C; McIntyre P Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998 [TBL] [Abstract][Full Text] [Related]